NLRP3 and myocardial infarction: Given the unequal dynamics of plasma levels of IL-1β and NLRP3 protein observed in our study and their known pleiotropic effects, it is reasonable to assume that the potential use of anti-inflammatory treatment will have a different effect in subacute and remote periods of MI in different patients.